Literature DB >> 1988003

Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia.

K E Friday1, R A Failor, M T Childs, E L Bierman.   

Abstract

Polyunsaturated fatty acids in vegetable (n-6) and marine (n-3) oils have been shown to reduce cholesterol levels in normolipidemic individuals. However, there is relatively little information available on the lipoprotein responses to dietary n-6 and n-3 fatty acids in individuals with genetic forms of hyperlipidemia at risk for premature cardiovascular disease. We studied five subjects with heterozygous familial hypercholesterolemia (FH), as well as five normal controls, on three rigidly controlled diets differing primarily in their fatty acid composition. FH subjects reduced their total plasma cholesterol by 34% during the n-3 diet and by 26% with the n-6 diet (both p less than 0.001) when compared with values while on a butter diet. In addition, low density lipoprotein (LDL) cholesterol fell 31% and 29% (both p less than 0.001), and apolipoprotein B (apo B) levels dropped 28% and 27% (both p less than 0.01) during the n-3 and n-6 diets, respectively. A significant reduction of total and LDL cholesterol as well as of apo B was also noted in normal controls during n-3 and n-6 diets. Total plasma triglyceride and high density lipoprotein cholesterol fell significantly during n-3 diets in normal and FH subjects. Thus, FH and normal subjects respond in a similar fashion to diets low in saturated fatty acids and rich in n-3 and n-6, with decreased LDL cholesterol and apo B concentrations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988003     DOI: 10.1161/01.atv.11.1.47

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  8 in total

Review 1.  Fatty acid composition of the diet: impact on serum lipids and atherosclerosis.

Authors:  N Zöllner; F Tatò
Journal:  Clin Investig       Date:  1992-11

2.  Familial Hypercholesterolemia.

Authors:  Paul N. Hopkins
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

3.  Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR(-/-) mice.

Authors:  Ganesan Murali; Ginger L Milne; Corey D Webb; Ann B Stewart; Ryan P McMillan; Brandon C Lyle; Matthew W Hulver; Viswanathan Saraswathi
Journal:  J Lipid Res       Date:  2012-07-29       Impact factor: 5.922

4.  Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids.

Authors:  Catherine Le Jossic-Corcos; Céline Gonthier; Isabelle Zaghini; Emmanuelle Logette; Ishaiahu Shechter; Paulette Bournot
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

Review 5.  Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.

Authors:  Anita Malhotra; Nusrat Shafiq; Anjuman Arora; Meenu Singh; Rajendra Kumar; Samir Malhotra
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10

Review 6.  Omega-3 fatty acids. Current status in cardiovascular medicine.

Authors:  E B Schmidt; J Dyerberg
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 7.  Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management.

Authors:  Maria Mytilinaiou; Ioannis Kyrou; Mike Khan; Dimitris K Grammatopoulos; Harpal S Randeva
Journal:  Front Pharmacol       Date:  2018-07-12       Impact factor: 5.810

8.  Impact of Diet on Plasma Lipids in Individuals with Heterozygous Familial Hypercholesterolemia: A Systematic Review of Randomized Controlled Nutritional Studies.

Authors:  Gabrielle Roy; Anykim Boucher; Patrick Couture; Jean-Philippe Drouin-Chartier
Journal:  Nutrients       Date:  2021-01-15       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.